Clostridioides difficile peptidoglycan

Peptidoglycan from Clostridioides (formerly Clostridium) difficile is a key structural component of its cell wall, providing physical integrity and resistance to osmotic lysis[7]. It is an atypical bacterial peptidoglycan notable for its remarkably high level of N-acetylglucosamine deacetylation and a predominance of unusual 3–3 peptide cross-links, which are catalyzed by a family of L,D-transpeptidases[1][5]. These features grant high intrinsic resistance to lysozyme (a host defense enzyme), with two main deacetylases (PgdA and PdaV) redundantly protecting the glycan chains[2]. Peptidoglycan biosynthesis and cross-linking enzymes, especially L,D-transpeptidases, are essential for C. difficile viability and are considered promising targets for narrow-spectrum antibiotics because classic penicillin-binding proteins contribute less to cross-linking compared to most bacteria[3][5]. Peptidoglycan is also the substrate for various cell wall hydrolases and sortases, which play a role in envelope remodeling and protein anchoring[6]. Disrupting its synthesis or modification results in loss of viability, making the peptidoglycan layer a validated therapeutic target in C. difficile infection[5][2][7].

Other names

C. difficile peptidoglycanClostridium difficile peptidoglycanC. difficile cell wall peptidoglycanClostridioides difficile PG

Inhibition of peptidoglycan biosynthesis (e.g., by penicillin-binding proteins); Inhibition of cross-linking enzymes (L,D-transpeptidases) crucial for 3–3 cross-links; Disruption of cell wall assembly leading to bacterial lysis and death